πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 35 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12421287

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12257311

Multimeric T-cell modulatory polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12180258

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12152061

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12146150

Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intraven

VOYAGER THERAPEUTICS, INC. Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12145973

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12029782

MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellit

Cue Biopharma, Inc. Β· Granted Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12006348

T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11993641

Methods for modulating an immune response

Cue Biopharma, Inc. Β· Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11987610

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11958893

Methods for modulating an immune response

Cue Biopharma, Inc. Β· Granted Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11905320

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11878062

Multimeric T-cell modulatory polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11851471

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11851467

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11767355

Methods for modulating an immune response

Cue Biopharma, Inc. Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11739133

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11708400

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11702461

T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory pol

Cue Biopharma, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11692018

TGF-Ξ² polypeptides

Cue Biopharma, Inc. Β· Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11530248

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11505591

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11505588

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11479595

Methods for modulating an immune response

Cue Biopharma, Inc. Β· Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted